BiomX (PHGE) Restructuring Costs (2019 - 2023)
BiomX (PHGE) posted Restructuring Costs of $187000.0 for Q2 2023, down 27.8% sequentially from $259000.0 in Q3 2022, and down 3.61% YoY from $194000.0 in Q2 2022.
BiomX (PHGE) Restructuring Costs (2019 - 2023) Analysis & Trends
BiomX has reported Restructuring Costs for 5 years, with the latest figure at $187000.0 in Q2 2023.
- Quarterly Restructuring Costs fell 3.61% year-over-year to $187000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $1.1 million (down 3.98% YoY) and the FY2024 annual result came in at $1.0 million, up 7.32% from the prior year.
- Restructuring Costs slipped to $187000.0 in Q2 2023 per PHGE's latest filing, from $259000.0 in the prior quarter.
- Over five years, Restructuring Costs peaked at $446000.0 in Q3 2021 and troughed at $110000.0 in Q1 2019.
- A 5-year average of $257833.3 and a median of $261500.0 in 2019 frame the typical range for Restructuring Costs.
- The sharpest annual moves came in 2021 and 2022: Restructuring Costs jumped 64.58% in 2021, then tumbled 41.93% in 2022.
- Over 5 years, Restructuring Costs stood at $360000.0 in 2019, then declined by 18.89% to $292000.0 in 2020, then surged by 52.74% to $446000.0 in 2021, then sank by 41.93% to $259000.0 in 2022, then fell by 27.8% to $187000.0 in 2023.
- According to Business Quant data, Restructuring Costs over the past three periods registered $187000.0, $259000.0, and $194000.0 for Q2 2023, Q3 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | BiomX | 361,408.40 | -806,591.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 187,000.00 |
| Sep 30, 2022 | 259,000.00 |
| Jun 30, 2022 | 194,000.00 |
| Sep 30, 2021 | 446,000.00 |
| Mar 31, 2021 | 199,000.00 |
| Dec 31, 2020 | 292,000.00 |
| Sep 30, 2020 | 271,000.00 |
| Jun 30, 2020 | 367,000.00 |
| Mar 31, 2020 | 145,000.00 |
| Sep 30, 2019 | 360,000.00 |
| Jun 30, 2019 | 264,000.00 |
| Mar 31, 2019 | 110,000.00 |